Tokyo, Japan

Tutomu Ebata

This inventor holds 5 USPTO granted patents. Top assignees: Daiichi Pharmaceutical Co., Ltd., Daiichi Seiyaku Co., Ltd.. Active years: 1992-2001.


% Patents Active = 100.0

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Toyko, JP (1999)
  • Tokyo, JP (1992 - 2001)

Company Filing History:


Years Active: 1992-2001

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Tutomu Ebata: Innovator in Antibacterial Compounds

Introduction

Tutomu Ebata is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of chemistry, particularly in the development of antibacterial agents. With a total of 5 patents to his name, his work has had a considerable impact on pharmaceutical innovations.

Latest Patents

Ebata's latest patents include a production process for cyclic compounds. One of his notable inventions is a compound represented by formula (III). This invention aims to provide a compound represented by formula (I) and a compound represented by formula (II), which are useful as antibacterial agents. The synthetic process he developed is designed to be inexpensive, short-step, and industrially advantageous for the production of these compounds.

Career Highlights

Throughout his career, Ebata has worked with prominent companies in the pharmaceutical industry, including Daiichi Pharmaceutical Co., Ltd. and Daiichi Seiyaku Co., Ltd. His expertise in the field has allowed him to contribute to various innovative projects and advancements.

Collaborations

Ebata has collaborated with several professionals in his field, including Toshifumi Akiba and Keiichi Hirai. These collaborations have further enhanced his research and development efforts.

Conclusion

Tutomu Ebata's contributions to the field of antibacterial compounds highlight his innovative spirit and dedication to advancing pharmaceutical science. His work continues to influence the industry and pave the way for future developments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…